Topics

US-China trade deal sees changes on drug patents

06:22 EST 16 Jan 2020 | Pharmafile

The US and China signed the first part of a broader trade pact that included setting up a system to resolve conflicts over drug patents between the two countries.

In a statement the Trump administration said: “Robust protection of intellectual property is critical to incentivizing the development of new and innovative treatments and cures.”

read more

Original Article: US-China trade deal sees changes on drug patents

NEXT ARTICLE

More From BioPortfolio on "US-China trade deal sees changes on drug patents"

Quick Search

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...